Trillium Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $219K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $289K | Hold |
|
|||||
|
2023
Q2 | $318K | Sell |
|
|||||
|
2023
Q1 | $364K | Sell |
|
|||||
|
2022
Q4 | $435K | Sell |
|
|||||
|
2022
Q3 | $452K | Hold |
|
|||||
|
2022
Q2 | $490K | Hold |
|
|||||
|
2022
Q1 | $465K | Sell |
|
|||||
|
2021
Q4 | $399K | Sell |
|
|||||
|
2021
Q3 | $395K | Sell |
|
|||||
|
2021
Q2 | $469K | Sell |
|
|||||
|
2021
Q1 | $482K | Hold |
|
|||||
|
2020
Q4 | $474K | Buy |
|
|||||
|
2020
Q3 | $236K | Sell |
|
|||||
|
2020
Q2 | $322K | Sell |
|
|||||
|
2020
Q1 | $459K | Sell |
|
|||||
|
2019
Q4 | $1.69M | Buy |
|
|||||
|
2019
Q3 | $314K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $288K | Buy |
|
|||||
|
2017
Q4 | $270K | Buy |
|
|||||
|
2017
Q3 | $267K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $376K | Sell |
|
|||||
|
2016
Q3 | $360K | Sell |
|
|||||
|
2016
Q2 | $550K | Sell |
|
|||||
|
2016
Q1 | $609K | Buy |
|
|||||
|
2015
Q4 | $531K | Sell |
|
|||||
|
2015
Q3 | $466K | Hold |
|
|||||
|
2015
Q2 | $523K | Sell |
|
|||||
|
2015
Q1 | $530K | Sell |
|
|||||
|
2014
Q4 | $495K | Buy |
|
|||||
|
2014
Q3 | $347K | Buy |
|
|||||
|
2014
Q2 | $271K | Hold |
|
|||||
|
2014
Q1 | $290K | Hold |
|
|||||
|
2013
Q4 | $297K | Sell |
|
|||||
|
2013
Q3 | $348K | Buy |
|
|||||
|
2013
Q2 | $272K | Buy |
|